McGuire Investment Group LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 1.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 189,476 shares of the exchange traded fund’s stock after selling 2,554 shares during the quarter. SPDR […]